Parmax Pharma
add_icon

Parmax Pharma

81.26
+1.59
(2.00%)
Market Cap
30.39 Cr
PE Ratio
-7.16
Volume
988.00
Day High - Low
81.26 - 81.26
52W High-Low
79.67 - 22.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
30.39 Cr
EPS
-11.12
PE Ratio
-7.16
PB Ratio
-4.35
Book Value
-18.33
EBITDA
-3.64
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
105.30
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
neutral
Parmax Pharma issued a corrigendum to its EGM notice dated June 8, 2026, correcting the category of Ms. Sheetal Hiren Doshi and a hyperlink for the Practicing Company Secretary's Certificate. The EGM is scheduled for July 2, 2026.
neutral
Pradeep Gosalia disposed of 3,00,000 equity shares in Parmax Pharma Ltd, reducing his holding to 0.07% via a share purchase agreement.
neutral
Acquirers Dhiren Chandulal Shah and Sunil Chinubhai Shah have launched a mandatory open offer to acquire up to 26% stake in Parmax Pharma Limited at ₹42.80 per share. The offer, aggregating to ₹10.04 crore, follows a share purchase agreement and preferential issue.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,877.40
#1 4,50,451.15
38.90
#1 58,220.10
6.38
#1 11,565
25.80
61.23
6,613.50
1,75,567.65
67.64
10,560.00
8.73
2,520
13.44
42.94
4,636.60
1,56,923.61
73.47
13,886.20
20.34
2,138
-26.91
63.51
1,461.70
1,18,082.75
30.48
29,044.60
2.24
3,870
-55.32
66.61
1,347.70
1,12,488.35
26.89
33,593.30
-0.44
3,998
-86.05
60.09
1,105.40
1,11,229.11
21.78
26,719.70
13.65
5,242
7.82
61.31
2,399.10
1,09,694.66
#1 20.46
27,487.50
19.98
5,345
#1 87.72
63.18
2,497.70
1,03,154.01
53.06
14,277.60
12.03
1,750
31.75
57.28
1,555.00
89,471.26
25.75
33,384.70
3.21
3,376
1.99
62.66
1,509.60
81,496.75
90.63
6,867.80
#1 22.01
890
21.18
66.46
Growth Rate
Revenue Growth
-57.06 %
Net Income Growth
178.57 %
Cash Flow Change
-380.00 %
ROE
-101.93 %
ROCE
-61.52 %
EBITDA Margin (Avg.)
-2,977.88 %

Yearly Financial Results

Annual Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
0
0
12
12
21
26
18
16
11
28
12
Expenses
0
0
11
11
19
23
16
13
14
28
16
EBITDA
0
0
1
1
2
4
3
2
-3
0
-4
Operating Profit %
0 %
0 %
9 %
9 %
8 %
13 %
14 %
15 %
-31 %
1 %
-30 %
Depreciation
0
0
1
1
1
2
2
2
2
1
1
Interest
0
0
0
0
0
0
0
0
1
1
1
Profit Before Tax
0
0
0
0
1
1
0
0
-6
-2
-6
Tax
0
0
0
0
0
1
0
0
0
-0
0
Net Profit
0
0
0
0
0
1
0
-0
-6
-2
-6
EPS in ₹
-0.01
-0.02
0.00
0.21
1.15
2.02
0.38
-0.28
-34.56
-5.60
-11.12

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
5
8
17
20
21
23
18
18
15
19
28
Fixed Assets
3
3
6
5
10
11
10
10
9
8
8
Current Assets
2
4
9
9
9
10
7
8
6
10
17
Capital Work in Progress
0
0
0
3
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
8
Other Assets
3
5
11
11
11
12
8
8
6
10
0
Total Equity & Liabilities
5
8
17
20
21
23
18
18
15
19
28
Current Liabilities
0
2
10
10
11
11
7
7
9
13
23
Non Current Liabilities
1
1
2
5
5
6
5
5
6
8
12
Total Equity
5
5
5
5
5
6
6
6
0
-2
-6
Reserve & Surplus
0
0
0
0
1
1
2
1
-4
-6
-11
Share Capital
5
5
5
5
5
5
5
5
5
5
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
0
-0
1
1
0
1
-2
-1
-0
-0
Investing Activities
0
0
-0
-4
-3
-2
-3
-2
-1
-2
-1
Operating Activities
-0
0
-1
4
1
3
4
1
0
-0
-1
Financing Activities
0
0
1
1
3
-0
0
-1
0
1
1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.83 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
30.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
68.09 %
68.03 %
67.93 %
67.98 %
68.01 %
68.00 %
65.37 %
65.36 %
65.38 %
65.42 %
65.43 %
65.43 %
65.34 %
65.78 %
62.90 %
63.12 %
63.10 %
63.10 %
63.09 %
63.08 %
63.10 %
Others
1.10 %
1.17 %
1.27 %
1.22 %
1.19 %
1.20 %
3.83 %
3.84 %
3.81 %
3.78 %
3.76 %
3.77 %
3.83 %
3.42 %
6.29 %
6.08 %
6.10 %
6.10 %
6.11 %
6.12 %
6.09 %
No of Share Holders
0
928
1,188
1,344
1,526
1,551
1,590
1,01,650
1,997
1,978
1,973
2,002
2,099
2,185
2,246
2,334
2,356
2,377
2,399
2,393
2,388

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Jul 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
02 Jul 2026 45.73 79.67
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 44.20 49.08
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 46.70 48.91
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 43.50 41.00
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 45.90 45.40
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 35.40 36.15
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 33.22 32.01
17 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Nov 2025 32.60 32.00
14 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2026 32.56 32.00
27 May 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
27 May 2026 30.02 37.90
02 Jun 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Jun 2026 37.90 39.00

Announcements

Closure of Trading Window3 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The Company8 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Draft Letter of Offer9 days ago
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations 2011Jun 19, 2026
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations 2011Jun 17, 2026
Detailed Public StatementJun 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 11, 2026
EGM Scheduled To Be Held On July 02 2026Jun 09, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 09, 2026
Open OfferJun 09, 2026
Board Meeting Outcome for Outcome Of Board MeetingJun 08, 2026
Board Meeting Intimation for Fund RaisingJun 03, 2026
Results-Delay in Financial ResultsJun 03, 2026
Board Meeting Outcome for Outcome Of Board MeetingJun 03, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMMay 31, 2026
Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended Marc 31 2026May 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 28, 2026
Board Meeting Intimation for Considering Audited Financial Results Of Quarter And Financial Year Ended On March 31 2026May 27, 2026
Extra Ordinary General Meeting Scheduled To Be Held On May 27 2026May 04, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 02, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2026
Closure of Trading WindowMar 30, 2026
Appointment of Company Secretary and Compliance OfficerMar 25, 2026
Unaudited Financial Results For Quarter And Nine Months Ended 31.12.2025Feb 14, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 14, 2026
Board Meeting Intimation for Consider And Approve Unaudited Financial Results For Quarter And Nine Months Ended On December 31 2025Feb 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 30, 2025
Results-Delay in Financial ResultsNov 17, 2025
Board Meeting Outcome for The Board Meeting Was Initially Rescheduled On November 15 2025 And Thenafter On Today I.E. November 17 2025 Hence Board Has Approved The Unaudited Financial Statements For Quarter And Half Year Ended On September 30 2025Nov 17, 2025
Board Meeting Intimation for Reschedule Of Board Meeting Supposed To Be Held On November 14 2025Nov 15, 2025
Board Meeting Intimation for For Approval Of Unaudited Financial Results For Quarter Ended September 30 2025Nov 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 02, 2025
Closure of Trading WindowOct 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Notice Of Thirty First Annual General Meeting Of The CompanySep 06, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Financial Statements For Quarter Ended 30Th June 2025Aug 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Unaudited Financial Results For Quarter Ended 30Th June 2025Aug 14, 2025
Board Meeting Outcome for For Approval Of Financial Results Of Quarter Ended 30Th June 2025Aug 14, 2025
Board Meeting Intimation for Board Meeting To Be Held For Considering Unaudited Financial Statements Of The Company For Quarter Ended June 30 2025Aug 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 01, 2025

Technical Indicators

RSI(14)
Overbought
89.58
ATR(14)
Less Volatile
2.46
STOCH(9,6)
Overbought
100.00
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.88
ADX(14)
Very Strong Trend
67.87
UO(9)
Bearish
96.43
ROC(12)
Uptrend And Accelerating
34.31
WillR(14)
Overbought
0.00